Vieworks Co., Ltd. (KOSDAQ:100120)
19,050
-240 (-1.24%)
Nov 21, 2025, 3:30 PM KST
Vieworks Market Cap
Vieworks has a market cap or net worth of 170.91 billion as of November 21, 2025. Its market cap has decreased by -23.40% in one year.
Market Cap
170.91B
Enterprise Value
199.59B
Revenue
225.23B
Ranking
n/a
PE Ratio
11.61
Stock Price
19,050.00
Market Cap Chart
Since April 10, 2009, Vieworks's market cap has increased from 125.19B to 170.91B, an increase of 36.51%. That is a compound annual growth rate of 1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 170.91B | -12.20% |
| Dec 30, 2024 | 194.66B | -21.48% |
| Dec 28, 2023 | 247.91B | -10.45% |
| Dec 29, 2022 | 276.83B | -29.06% |
| Dec 30, 2021 | 390.25B | 36.09% |
| Dec 30, 2020 | 286.77B | -7.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.29T |
| ALTEOGEN | 28.93T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Peptron | 9.00T |
| Yuhan | 8.73T |
| LigaChem Biosciences | 6.49T |